Your browser doesn't support javascript.
loading
Standardization of key performance indicators and metrics for investigational drug services: Consensus recommendations among IDS specialists.
Schmidt, Molly; Carlson, Lisa Janssen; Murphy, Jennifer; Amin, Sapna R; Lockhorst, Robin; Luedtke, Kyle.
Afiliación
  • Schmidt M; Avera McKennan Hospital & University Health Center, Sioux Falls, SD, USA.
  • Carlson LJ; University of California, San Francisco Medical Center, San Francisco, CA, USA.
  • Murphy J; UC Davis Medical Center, Davis, CA.
  • Amin SR; UC Davis Comprehensive Cancer Center, Davis, CA, USA.
  • Lockhorst R; MD Anderson Cancer Center, Houston, TX, USA.
  • Luedtke K; Avera Cancer Institute, Sioux Falls, SD, USA.
Am J Health Syst Pharm ; 81(14): 608-614, 2024 Jul 08.
Article en En | MEDLINE | ID: mdl-38502866
ABSTRACT

PURPOSE:

There are currently no consensus guidelines on establishing metrics for investigational drug services (IDS). Because of the complexity of research protocols, it remains difficult for sites to track pharmacy productivity and create a baseline for IDS growth within the institution, as well as to perform benchmarking with peer institutions. The goal of this study was to help establish practical guidance for IDS metrics and site utility as applicable.

METHODS:

This was a survey-based project conducted by the metrics subgroup of the Hematology/Oncology Pharmacy Association (HOPA) IDS special interest group (SIG), which was formed specifically for this analysis. Three surveys developed by the metrics subgroup were sent to members of the IDS HOPA SIG to gather metrics. The first survey included questions about what metrics IDS sites currently collect. The identified metrics were then condensed into categories. Through a consensus-based approach, standardized definitions were established and applied to future surveys. The 2 subsequent surveys sent to HOPA SIG members helped create a list of top recommended metrics that are recommended for every IDS site to track.

RESULTS:

A total of 3 surveys were sent to 75 recipients, with the response rate ranging from 24% to 38%. From these surveys and consensus with the metrics subgroup, 5 top recommended metrics were identified (1) active protocols; (2) dispenses; (3) new clinical trials initiated; (4) patients treated; and (5) clinical interventions.

CONCLUSION:

These recommended metrics should serve as guidance and allow for standardization to help ensure adequate resources are available for IDS pharmacy staff. These recommendations should serve as a basis for standardization and benchmarking with peer institutions.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Drogas en Investigación / Benchmarking / Consenso Límite: Humans Idioma: En Revista: Am J Health Syst Pharm Asunto de la revista: FARMACIA / HOSPITAIS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Drogas en Investigación / Benchmarking / Consenso Límite: Humans Idioma: En Revista: Am J Health Syst Pharm Asunto de la revista: FARMACIA / HOSPITAIS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido